Cytori Therapeutics Inc (NASDAQ:CYTX) entered into a four year, $17.7 million term loan withOxford Finance LLC.
In a research report released Tuesday, Oppenheimer analyst Christopher Marai maintained an Outperform rating on Cytori Therapeutics Inc (NASDAQ:CYTX) with a $10 price target, following …
Cytori Therapeutics Inc (NASDAQ:CYTX) presented data from two preclinical studies funded through its contract with the United States Biomedical Advanced Research and Development Authority …
The investment firm Roth Capital was out with a research report on Cytori Therapeutics Inc (NASDAQ:CYTX), following the news that the company's regenerative cell technology system, Celution, has …
In a research report issued today, Roth Capital analyst Joseph Pantginis reiterated a Buy rating on Cytori Therapeutics Inc (NASDAQ:CYTX) with a $6 price …
